A Randomized, Open-label, Parallel Group, Multicenter Phase IV Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management:TICAKOREA Trial
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- Acronyms TICA KOREA
- 19 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Jun 2016 Planned End Date changed from 1 Dec 2017 to 1 Jun 2020.
- 13 Jun 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jan 2020.